Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP337101.RAEhbby688NuqkIW9Nt36BgqJTntcSUQwIgGr7uAGuxts130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP337101.RAEhbby688NuqkIW9Nt36BgqJTntcSUQwIgGr7uAGuxts130_assertion type Assertion NP337101.RAEhbby688NuqkIW9Nt36BgqJTntcSUQwIgGr7uAGuxts130_head.
- NP337101.RAEhbby688NuqkIW9Nt36BgqJTntcSUQwIgGr7uAGuxts130_assertion description "[Three of 8 clear (38%) cell carcinomas and 7 of 25 serous carcinomas (28%) screened exhibited HER2 amplification compared with 7% (2/29) of endometrioid adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP337101.RAEhbby688NuqkIW9Nt36BgqJTntcSUQwIgGr7uAGuxts130_provenance.
- NP337101.RAEhbby688NuqkIW9Nt36BgqJTntcSUQwIgGr7uAGuxts130_assertion evidence source_evidence_literature NP337101.RAEhbby688NuqkIW9Nt36BgqJTntcSUQwIgGr7uAGuxts130_provenance.
- NP337101.RAEhbby688NuqkIW9Nt36BgqJTntcSUQwIgGr7uAGuxts130_assertion SIO_000772 19840887 NP337101.RAEhbby688NuqkIW9Nt36BgqJTntcSUQwIgGr7uAGuxts130_provenance.
- NP337101.RAEhbby688NuqkIW9Nt36BgqJTntcSUQwIgGr7uAGuxts130_assertion wasDerivedFrom befree-20140225 NP337101.RAEhbby688NuqkIW9Nt36BgqJTntcSUQwIgGr7uAGuxts130_provenance.
- NP337101.RAEhbby688NuqkIW9Nt36BgqJTntcSUQwIgGr7uAGuxts130_assertion wasGeneratedBy ECO_0000203 NP337101.RAEhbby688NuqkIW9Nt36BgqJTntcSUQwIgGr7uAGuxts130_provenance.